Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega

Given the medical necessity of Cisatracurium Omega (Cisatracurium Besylate Injection 2 mg/mL ) and to maintain continuity of supply in Canada, Health Canada has authorized the exceptional, temporary importation and sale of Italian-authorized Cisatracurio Hikma 2 mg/mL with Italian-only labels by Hikma Canada Limited to mitigate the shortage.

Packaging - Product safety - Supply

Cisatracurio Hikma 2 mg/mL Ampoules

RA-75277